On September 10th, the 6th China Medical Device Summit opened in Suzhou. More than 400 guests from science and technology innovation enterprises, government agencies, industry associations and academic institutions discussed the innovation and fission of China's medical device industry . . On the same day, 23 high-end implanted R&D companies and research institutes in China jointly launched the Lakeside Medical Intervention Industry Research Institute, aiming at strengthening exchanges and cooperation and accelerating the research and development of new products.
"For a long time, domestic high-end medical equipment is mainly imported, and 70% of the domestic market is occupied by foreign companies. Medical equipment purchase fees and maintenance fees have been high, and ordinary patients can't afford it." Lakeside medical implant industry Yan Tingfei, president of the institute, said that to change this situation, it is necessary to develop local medical device brands and break foreign monopolies. Yan Tingfei used the drug heart stent as an example. “In the domestic market, the brackets of well-known foreign brands were almost no less than 40,000 yuan. Later, the same type of products from three domestic companies were listed, and the price was only 10,000 yuan. Immediately, it fell. At present, the average import bracket price is about 20,000, and domestic products are only seven or eight thousand."
However, at present, domestic medical device companies tend to produce low-end products, with low technical content and low added value. "The medical device industry wants to break out of the predicament and can only rely on innovation, not just technological innovation, but also strengthen the cooperation between production, learning, research, medicine, and investment." Pang Junyong, president of Suzhou Bio-Nano Park, introduced as a big health An important part of the industry, the medical device industry has a long development cycle, from research and development, reporting, clinical trials, to final listing, generally three to five years. In this process, the capital investment is huge, and the cost of hundreds of millions of dollars makes most enterprises unbearable. Many enterprises can only research and develop, while trying to raise funds, the efficiency is greatly reduced.
"Under this situation, the living space of SMEs is getting smaller and smaller, and the role of the alliance will be more and more large. Domestic medical equipment companies may wish to develop and integrate government, capital, entrepreneurs, scientists and other resources." Pang Junyong said . According to reports, Suzhou Bio-Nano Park has gathered more than 430 bio-pharmaceutical companies, including more than 100 independent innovation-type medical device R&D and production enterprises, including Jingyi Medical, VIA Nas, Chenchen Medical, and Kangzhong Medical. The vast majority of enterprises at the Lakeside Medical Implantation Industry Research Institute are also located in Suzhou Bio-Nano Park, and are committed to building a medical device industry ecosystem.
Irrigation Solutions,Sodium Chloride Physiological Solution,Physiological Solution,Mannitol Irrigation Solution
Shandong Qidu Pharmaceutical Co., Ltd. , https://www.qdyypharma.com